vs
Side-by-side financial comparison of Huntington Ingalls Industries (HII) and Kenvue (KVUE). Click either name above to swap in a different company.
Kenvue is the larger business by last-quarter revenue ($3.8B vs $3.5B, roughly 1.1× Huntington Ingalls Industries). Kenvue runs the higher net margin — 8.7% vs 4.6%, a 4.2% gap on every dollar of revenue. On growth, Huntington Ingalls Industries posted the faster year-over-year revenue change (15.7% vs 3.2%). Kenvue produced more free cash flow last quarter ($744.0M vs $516.0M). Over the past eight quarters, Huntington Ingalls Industries's revenue compounded faster (11.3% CAGR vs -1.5%).
Huntington Ingalls Industries, Inc. (HII) is the largest military shipbuilding company in the United States as well as a provider of professional services to partners in government and industry. HII was formed on 31 March 2011, as a divestiture from Northrop Grumman.
Kenvue Inc. is an American consumer health company. Formerly the Consumer Healthcare division of Johnson & Johnson, Kenvue owns well-known brands such as Aveeno, Band-Aid, Benadryl, Combantrin, Zyrtec, Johnson's, Listerine, Lactaid, Mylanta, Neutrogena, Trosyd, Calpol, Tylenol, and Visine. Kenvue is incorporated in Delaware and was originally headquartered in the Skillman section of Montgomery Township, New Jersey, before relocating to Summit, New Jersey.
HII vs KVUE — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $3.5B | $3.8B |
| Net Profit | $159.0M | $330.0M |
| Gross Margin | — | 56.5% |
| Operating Margin | 4.9% | 14.2% |
| Net Margin | 4.6% | 8.7% |
| Revenue YoY | 15.7% | 3.2% |
| Net Profit YoY | 29.3% | 12.6% |
| EPS (diluted) | $4.06 | $0.16 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $3.5B | $3.8B | ||
| Q3 25 | $3.2B | $3.8B | ||
| Q2 25 | $3.1B | $3.8B | ||
| Q1 25 | $2.7B | $3.7B | ||
| Q4 24 | $3.0B | $3.7B | ||
| Q3 24 | $2.7B | $3.9B | ||
| Q2 24 | $3.0B | $4.0B | ||
| Q1 24 | $2.8B | $3.9B |
| Q4 25 | $159.0M | $330.0M | ||
| Q3 25 | $145.0M | $398.0M | ||
| Q2 25 | $152.0M | $420.0M | ||
| Q1 25 | $149.0M | $322.0M | ||
| Q4 24 | $123.0M | $293.0M | ||
| Q3 24 | $101.0M | $383.0M | ||
| Q2 24 | $173.0M | $58.0M | ||
| Q1 24 | $153.0M | $296.0M |
| Q4 25 | — | 56.5% | ||
| Q3 25 | — | 59.1% | ||
| Q2 25 | — | 58.9% | ||
| Q1 25 | — | 58.0% | ||
| Q4 24 | — | 56.5% | ||
| Q3 24 | — | 58.5% | ||
| Q2 24 | — | 59.1% | ||
| Q1 24 | — | 57.6% |
| Q4 25 | 4.9% | 14.2% | ||
| Q3 25 | 5.0% | 16.7% | ||
| Q2 25 | 5.3% | 18.0% | ||
| Q1 25 | 5.9% | 14.9% | ||
| Q4 24 | 3.7% | 13.2% | ||
| Q3 24 | 3.0% | 16.8% | ||
| Q2 24 | 6.3% | 3.9% | ||
| Q1 24 | 5.5% | 14.1% |
| Q4 25 | 4.6% | 8.7% | ||
| Q3 25 | 4.5% | 10.6% | ||
| Q2 25 | 4.9% | 10.9% | ||
| Q1 25 | 5.4% | 8.6% | ||
| Q4 24 | 4.1% | 8.0% | ||
| Q3 24 | 3.7% | 9.8% | ||
| Q2 24 | 5.8% | 1.5% | ||
| Q1 24 | 5.5% | 7.6% |
| Q4 25 | $4.06 | $0.16 | ||
| Q3 25 | $3.68 | $0.21 | ||
| Q2 25 | $3.86 | $0.22 | ||
| Q1 25 | $3.79 | $0.17 | ||
| Q4 24 | $3.15 | $0.16 | ||
| Q3 24 | $2.56 | $0.20 | ||
| Q2 24 | $4.38 | $0.03 | ||
| Q1 24 | $3.87 | $0.15 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $1.1B |
| Total DebtLower is stronger | $2.7B | — |
| Stockholders' EquityBook value | $5.1B | $10.8B |
| Total Assets | $12.7B | $27.1B |
| Debt / EquityLower = less leverage | 0.53× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $1.1B | ||
| Q3 25 | — | $1.1B | ||
| Q2 25 | — | $1.1B | ||
| Q1 25 | — | $1.1B | ||
| Q4 24 | — | $1.1B | ||
| Q3 24 | — | $1.1B | ||
| Q2 24 | — | $1.0B | ||
| Q1 24 | $10.0M | $1.2B |
| Q4 25 | $2.7B | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $2.7B | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $5.1B | $10.8B | ||
| Q3 25 | $5.0B | $10.6B | ||
| Q2 25 | $4.9B | $10.7B | ||
| Q1 25 | $4.8B | $10.1B | ||
| Q4 24 | $4.7B | $9.7B | ||
| Q3 24 | $4.2B | $10.6B | ||
| Q2 24 | $4.2B | $10.2B | ||
| Q1 24 | $4.1B | $10.6B |
| Q4 25 | $12.7B | $27.1B | ||
| Q3 25 | $12.3B | $27.2B | ||
| Q2 25 | $12.1B | $27.1B | ||
| Q1 25 | $12.1B | $26.3B | ||
| Q4 24 | $12.1B | $25.6B | ||
| Q3 24 | $11.1B | $26.9B | ||
| Q2 24 | $11.3B | $26.4B | ||
| Q1 24 | $11.2B | $27.3B |
| Q4 25 | 0.53× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.58× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $650.0M | $854.0M |
| Free Cash FlowOCF − Capex | $516.0M | $744.0M |
| FCF MarginFCF / Revenue | 14.8% | 19.7% |
| Capex IntensityCapex / Revenue | 3.9% | 2.9% |
| Cash ConversionOCF / Net Profit | 4.09× | 2.59× |
| TTM Free Cash FlowTrailing 4 quarters | $794.0M | $1.7B |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $650.0M | $854.0M | ||
| Q3 25 | $118.0M | $294.0M | ||
| Q2 25 | $823.0M | $621.0M | ||
| Q1 25 | $-395.0M | $428.0M | ||
| Q4 24 | $391.0M | $793.0M | ||
| Q3 24 | $213.0M | $249.0M | ||
| Q2 24 | $-9.0M | $440.0M | ||
| Q1 24 | $-202.0M | $287.0M |
| Q4 25 | $516.0M | $744.0M | ||
| Q3 25 | $13.0M | $196.0M | ||
| Q2 25 | $727.0M | $533.0M | ||
| Q1 25 | $-462.0M | $249.0M | ||
| Q4 24 | $277.0M | $661.0M | ||
| Q3 24 | $125.0M | $190.0M | ||
| Q2 24 | $-99.0M | $350.0M | ||
| Q1 24 | $-277.0M | $134.0M |
| Q4 25 | 14.8% | 19.7% | ||
| Q3 25 | 0.4% | 5.2% | ||
| Q2 25 | 23.6% | 13.9% | ||
| Q1 25 | -16.9% | 6.7% | ||
| Q4 24 | 9.2% | 18.1% | ||
| Q3 24 | 4.5% | 4.9% | ||
| Q2 24 | -3.3% | 8.8% | ||
| Q1 24 | -9.9% | 3.4% |
| Q4 25 | 3.9% | 2.9% | ||
| Q3 25 | 3.3% | 2.6% | ||
| Q2 25 | 3.1% | 2.3% | ||
| Q1 25 | 2.5% | 4.8% | ||
| Q4 24 | 3.8% | 3.6% | ||
| Q3 24 | 3.2% | 1.5% | ||
| Q2 24 | 3.0% | 2.3% | ||
| Q1 24 | 2.7% | 3.9% |
| Q4 25 | 4.09× | 2.59× | ||
| Q3 25 | 0.81× | 0.74× | ||
| Q2 25 | 5.41× | 1.48× | ||
| Q1 25 | -2.65× | 1.33× | ||
| Q4 24 | 3.18× | 2.71× | ||
| Q3 24 | 2.11× | 0.65× | ||
| Q2 24 | -0.05× | 7.59× | ||
| Q1 24 | -1.32× | 0.97× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HII
| Aircraftcarriers | $984.0M | 28% |
| Fixedpriceincentive | $758.0M | 22% |
| Submarines | $744.0M | 21% |
| Surfacecombatantsandcoastguardcutters | $452.0M | 13% |
| Amphibiousassaultships | $433.0M | 12% |
| Costtype | $123.0M | 4% |
| Otherprograms | $4.0M | 0% |
KVUE
| Self Care | $1.6B | 42% |
| Essential Health | $1.1B | 30% |
| Skin Health And Beauty | $1.0B | 28% |
